Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded Healthcare sector company. As of September 29, 2026, ALDX trades at $1.17 with a market cap of $72.69M and a P/E ratio of -2.20. ALDX moved +0.86% today. Year to date, ALDX is -77.61%; over the trailing twelve months it is -77.12%. Its 52-week range spans $1.07 to $7.20. Analyst consensus is neutral with an average price target of $2.00. Rallies surfaces ALDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ALDX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ALDX recently traded at $1.17. Market cap is $72.69M. P/E ratio is -2.20. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.17 |
| Market Cap | $72.69M |
| P/E Ratio | -2.20 |
| EPS | $-0.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.20 |
| 52-Week Low | $1.07 |
| Volume | 83.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-33.85M |
| Gross Margin | 0.00% |
1 analysts cover ALDX: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $2.00.